Allianz Asset Management GmbH Has $343,000 Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Key Points

• Allianz Asset Management GmbH reduced its stake in Pediatrix Medical Group by 53.8%, selling 27,600 shares and leaving them with 23,700 shares valued at approximately $343,000.
• Institutional investors own 97.71% of Pediatrix Medical Group, with significant changes from other hedge funds, including Nomura Asset Management and GAMMA Investing, increasing their investments substantially.
• Pediatrix Medical Group reported a quarterly earnings per share of $0.33, exceeding expectations, but noted a revenue decline of 7.4% year-over-year, with a current market capitalization of $1.03 billion.

Allianz Asset Management GmbH reduced its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 53.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,700 shares of the company's stock after selling 27,600 shares during the quarter. Allianz Asset Management GmbH's holdings in Pediatrix Medical Group were worth $343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of MD. California State Teachers Retirement System grew its position in Pediatrix Medical Group by 0.9% during the fourth quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock worth $1,054,000 after buying an additional 752 shares in the last quarter. SummerHaven Investment Management LLC lifted its stake in Pediatrix Medical Group by 0.9% during the first quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock worth $1,628,000 after purchasing an additional 1,028 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its stake in Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after purchasing an additional 1,220 shares during the last quarter. GAMMA Investing LLC lifted its stake in Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after purchasing an additional 1,765 shares during the last quarter. Finally, New York State Teachers Retirement System lifted its stake in Pediatrix Medical Group by 1.9% during the first quarter. New York State Teachers Retirement System now owns 133,313 shares of the company's stock worth $1,932,000 after purchasing an additional 2,527 shares during the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Price Performance

Shares of MD stock traded down $0.27 during trading hours on Friday, reaching $11.98. The company had a trading volume of 572,558 shares, compared to its average volume of 580,528. The stock has a fifty day moving average of $13.43 and a 200-day moving average of $13.83. The company has a market capitalization of $1.03 billion, a price-to-earnings ratio of -11.86 and a beta of 1.21. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.81 and a current ratio of 1.81. Pediatrix Medical Group, Inc. has a 12-month low of $7.47 and a 12-month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.08. The business had revenue of $458.36 million during the quarter, compared to analysts' expectations of $451.44 million. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The company's revenue was down 7.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.20 earnings per share. On average, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Truist Financial reduced their price target on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Macquarie upped their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Finally, UBS Group reduced their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a report on Monday, May 12th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $16.67.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.